nodes	percent_of_prediction	percent_of_DWPC	metapath
Propericiazine—ADRA1B—Amitriptyline—migraine	0.148	0.549	CbGbCtD
Propericiazine—Thiothixene—Amitriptyline—migraine	0.14	0.279	CrCrCtD
Propericiazine—ADRA2A—Amitriptyline—migraine	0.121	0.451	CbGbCtD
Propericiazine—Clomipramine—Amitriptyline—migraine	0.105	0.209	CrCrCtD
Propericiazine—Promethazine—Amitriptyline—migraine	0.0907	0.181	CrCrCtD
Propericiazine—Alimemazine—Amitriptyline—migraine	0.089	0.178	CrCrCtD
Propericiazine—Promazine—Amitriptyline—migraine	0.0767	0.153	CrCrCtD
Propericiazine—Hyperpyrexia—Amitriptyline—migraine	0.00436	0.0308	CcSEcCtD
Propericiazine—Tardive dyskinesia—Amitriptyline—migraine	0.00436	0.0308	CcSEcCtD
Propericiazine—Hyperprolactinaemia—Verapamil—migraine	0.00425	0.0301	CcSEcCtD
Propericiazine—Ileus paralytic—Amitriptyline—migraine	0.00375	0.0266	CcSEcCtD
Propericiazine—Neuroleptic malignant syndrome—Amitriptyline—migraine	0.00317	0.0225	CcSEcCtD
Propericiazine—Muscle rigidity—Amitriptyline—migraine	0.00317	0.0225	CcSEcCtD
Propericiazine—Ileus paralytic—Verapamil—migraine	0.00281	0.0199	CcSEcCtD
Propericiazine—Galactorrhoea—Amitriptyline—migraine	0.0025	0.0177	CcSEcCtD
Propericiazine—Tardive dyskinesia—Valproic Acid—migraine	0.00231	0.0164	CcSEcCtD
Propericiazine—Traumatic liver injury—Valproic Acid—migraine	0.00231	0.0164	CcSEcCtD
Propericiazine—Akinesia—Topiramate—migraine	0.00223	0.0158	CcSEcCtD
Propericiazine—Parkinsonism—Valproic Acid—migraine	0.0019	0.0134	CcSEcCtD
Propericiazine—Galactorrhoea—Verapamil—migraine	0.00187	0.0133	CcSEcCtD
Propericiazine—Dyskinesia—Amitriptyline—migraine	0.00173	0.0122	CcSEcCtD
Propericiazine—Atrioventricular block—Amitriptyline—migraine	0.00167	0.0118	CcSEcCtD
Propericiazine—Ventricular tachycardia—Amitriptyline—migraine	0.00162	0.0115	CcSEcCtD
Propericiazine—Menstruation irregular—Valproic Acid—migraine	0.00156	0.011	CcSEcCtD
Propericiazine—Gynaecomastia—Amitriptyline—migraine	0.00145	0.0103	CcSEcCtD
Propericiazine—Atrioventricular block—Propranolol—migraine	0.00136	0.00964	CcSEcCtD
Propericiazine—Galactorrhoea—Valproic Acid—migraine	0.00133	0.00941	CcSEcCtD
Propericiazine—Altered state of consciousness—Topiramate—migraine	0.0013	0.00922	CcSEcCtD
Propericiazine—Atrioventricular block—Verapamil—migraine	0.00125	0.00887	CcSEcCtD
Propericiazine—Gynaecomastia—Verapamil—migraine	0.00109	0.0077	CcSEcCtD
Propericiazine—Liver injury—Valproic Acid—migraine	0.00102	0.00725	CcSEcCtD
Propericiazine—Eosinophilia—Amitriptyline—migraine	0.00101	0.00714	CcSEcCtD
Propericiazine—Sweating increased—Amitriptyline—migraine	0.000992	0.00702	CcSEcCtD
Propericiazine—Deep vein thrombosis—Topiramate—migraine	0.000988	0.007	CcSEcCtD
Propericiazine—Amenorrhoea—Valproic Acid—migraine	0.000981	0.00694	CcSEcCtD
Propericiazine—Aggression—Valproic Acid—migraine	0.000981	0.00694	CcSEcCtD
Propericiazine—Menorrhagia—Gabapentin—migraine	0.000966	0.00683	CcSEcCtD
Propericiazine—Glaucoma—Gabapentin—migraine	0.000949	0.00672	CcSEcCtD
Propericiazine—Erectile dysfunction—Amitriptyline—migraine	0.000938	0.00664	CcSEcCtD
Propericiazine—Weight increased—Amitriptyline—migraine	0.000927	0.00656	CcSEcCtD
Propericiazine—Drowsiness—Amitriptyline—migraine	0.000908	0.00643	CcSEcCtD
Propericiazine—Atrioventricular block—Valproic Acid—migraine	0.000889	0.00629	CcSEcCtD
Propericiazine—Jaundice—Amitriptyline—migraine	0.000885	0.00627	CcSEcCtD
Propericiazine—Agranulocytosis—Amitriptyline—migraine	0.000847	0.006	CcSEcCtD
Propericiazine—Amenorrhoea—Gabapentin—migraine	0.000813	0.00576	CcSEcCtD
Propericiazine—Menorrhagia—Topiramate—migraine	0.000812	0.00575	CcSEcCtD
Propericiazine—Glaucoma—Topiramate—migraine	0.000799	0.00565	CcSEcCtD
Propericiazine—Atrioventricular block—Timolol—migraine	0.000791	0.0056	CcSEcCtD
Propericiazine—Erectile dysfunction—Propranolol—migraine	0.000764	0.00541	CcSEcCtD
Propericiazine—Dyskinesia—Gabapentin—migraine	0.00076	0.00538	CcSEcCtD
Propericiazine—Sweating increased—Verapamil—migraine	0.000743	0.00526	CcSEcCtD
Propericiazine—Atrioventricular block—Gabapentin—migraine	0.000737	0.00521	CcSEcCtD
Propericiazine—Arrhythmia—Amitriptyline—migraine	0.000728	0.00515	CcSEcCtD
Propericiazine—Pulmonary embolism—Gabapentin—migraine	0.000715	0.00506	CcSEcCtD
Propericiazine—Photosensitivity—Valproic Acid—migraine	0.000713	0.00504	CcSEcCtD
Propericiazine—Erectile dysfunction—Verapamil—migraine	0.000703	0.00497	CcSEcCtD
Propericiazine—Agranulocytosis—Propranolol—migraine	0.00069	0.00488	CcSEcCtD
Propericiazine—Amenorrhoea—Topiramate—migraine	0.000684	0.00484	CcSEcCtD
Propericiazine—Aggression—Topiramate—migraine	0.000684	0.00484	CcSEcCtD
Propericiazine—Drowsiness—Verapamil—migraine	0.00068	0.00481	CcSEcCtD
Propericiazine—Vision blurred—Amitriptyline—migraine	0.000669	0.00473	CcSEcCtD
Propericiazine—Increased appetite—Valproic Acid—migraine	0.000666	0.00471	CcSEcCtD
Propericiazine—Tremor—Amitriptyline—migraine	0.000665	0.00471	CcSEcCtD
Propericiazine—Jaundice—Verapamil—migraine	0.000663	0.00469	CcSEcCtD
Propericiazine—Agitation—Amitriptyline—migraine	0.000652	0.00462	CcSEcCtD
Propericiazine—Dyskinesia—Topiramate—migraine	0.00064	0.00453	CcSEcCtD
Propericiazine—Gynaecomastia—Gabapentin—migraine	0.000639	0.00453	CcSEcCtD
Propericiazine—Atrioventricular block—Topiramate—migraine	0.00062	0.00439	CcSEcCtD
Propericiazine—Cardiac disorder—Propranolol—migraine	0.000616	0.00436	CcSEcCtD
Propericiazine—Nasal congestion—Timolol—migraine	0.000612	0.00433	CcSEcCtD
Propericiazine—Pulmonary embolism—Topiramate—migraine	0.000601	0.00426	CcSEcCtD
Propericiazine—Dry mouth—Amitriptyline—migraine	0.000591	0.00418	CcSEcCtD
Propericiazine—Confusional state—Amitriptyline—migraine	0.000584	0.00413	CcSEcCtD
Propericiazine—Oedema—Amitriptyline—migraine	0.000579	0.0041	CcSEcCtD
Propericiazine—Tachycardia—Amitriptyline—migraine	0.000565	0.004	CcSEcCtD
Propericiazine—Hyperhidrosis—Amitriptyline—migraine	0.00056	0.00396	CcSEcCtD
Propericiazine—Increased appetite—Gabapentin—migraine	0.000552	0.00391	CcSEcCtD
Propericiazine—Hypotension—Amitriptyline—migraine	0.000541	0.00383	CcSEcCtD
Propericiazine—Eosinophilia—Valproic Acid—migraine	0.000536	0.00379	CcSEcCtD
Propericiazine—Agitation—Propranolol—migraine	0.000531	0.00376	CcSEcCtD
Propericiazine—Sweating increased—Valproic Acid—migraine	0.000527	0.00373	CcSEcCtD
Propericiazine—Insomnia—Amitriptyline—migraine	0.000524	0.00371	CcSEcCtD
Propericiazine—Somnolence—Amitriptyline—migraine	0.000515	0.00364	CcSEcCtD
Propericiazine—Vision blurred—Verapamil—migraine	0.000501	0.00355	CcSEcCtD
Propericiazine—Tremor—Verapamil—migraine	0.000498	0.00352	CcSEcCtD
Propericiazine—Constipation—Amitriptyline—migraine	0.000495	0.00351	CcSEcCtD
Propericiazine—Photosensitivity reaction—Valproic Acid—migraine	0.000494	0.00349	CcSEcCtD
Propericiazine—Weight increased—Valproic Acid—migraine	0.000492	0.00348	CcSEcCtD
Propericiazine—Agitation—Verapamil—migraine	0.000488	0.00346	CcSEcCtD
Propericiazine—Angioedema—Verapamil—migraine	0.000486	0.00344	CcSEcCtD
Propericiazine—Pneumonia—Valproic Acid—migraine	0.000485	0.00343	CcSEcCtD
Propericiazine—Drowsiness—Valproic Acid—migraine	0.000482	0.00341	CcSEcCtD
Propericiazine—Asthma—Timolol—migraine	0.000481	0.00341	CcSEcCtD
Propericiazine—Nasal congestion—Topiramate—migraine	0.000479	0.00339	CcSEcCtD
Propericiazine—Infection—Propranolol—migraine	0.000469	0.00332	CcSEcCtD
Propericiazine—Increased appetite—Topiramate—migraine	0.000465	0.00329	CcSEcCtD
Propericiazine—Body temperature increased—Amitriptyline—migraine	0.000458	0.00324	CcSEcCtD
Propericiazine—Agranulocytosis—Valproic Acid—migraine	0.00045	0.00319	CcSEcCtD
Propericiazine—Asthma—Gabapentin—migraine	0.000448	0.00317	CcSEcCtD
Propericiazine—Eosinophilia—Gabapentin—migraine	0.000444	0.00314	CcSEcCtD
Propericiazine—Erectile dysfunction—Timolol—migraine	0.000443	0.00314	CcSEcCtD
Propericiazine—Dry mouth—Verapamil—migraine	0.000443	0.00313	CcSEcCtD
Propericiazine—Confusional state—Verapamil—migraine	0.000437	0.0031	CcSEcCtD
Propericiazine—Sweating increased—Gabapentin—migraine	0.000437	0.00309	CcSEcCtD
Propericiazine—Hyperglycaemia—Timolol—migraine	0.000434	0.00307	CcSEcCtD
Propericiazine—Oedema—Verapamil—migraine	0.000434	0.00307	CcSEcCtD
Propericiazine—Infection—Verapamil—migraine	0.000431	0.00305	CcSEcCtD
Propericiazine—Insomnia—Propranolol—migraine	0.000427	0.00302	CcSEcCtD
Propericiazine—Tachycardia—Verapamil—migraine	0.000423	0.003	CcSEcCtD
Propericiazine—Dyspnoea—Propranolol—migraine	0.00042	0.00298	CcSEcCtD
Propericiazine—Hyperhidrosis—Verapamil—migraine	0.000419	0.00297	CcSEcCtD
Propericiazine—Somnolence—Propranolol—migraine	0.000419	0.00297	CcSEcCtD
Propericiazine—Erectile dysfunction—Gabapentin—migraine	0.000413	0.00292	CcSEcCtD
Propericiazine—Photosensitivity reaction—Gabapentin—migraine	0.000409	0.0029	CcSEcCtD
Propericiazine—Weight increased—Gabapentin—migraine	0.000408	0.00289	CcSEcCtD
Propericiazine—Hypotension—Verapamil—migraine	0.000405	0.00287	CcSEcCtD
Propericiazine—Hyperglycaemia—Gabapentin—migraine	0.000404	0.00286	CcSEcCtD
Propericiazine—Constipation—Propranolol—migraine	0.000403	0.00285	CcSEcCtD
Propericiazine—Pneumonia—Gabapentin—migraine	0.000402	0.00285	CcSEcCtD
Propericiazine—Agranulocytosis—Timolol—migraine	0.000401	0.00284	CcSEcCtD
Propericiazine—ADRA1B—G alpha (q) signalling events—HTR2B—migraine	0.0004	0.00503	CbGpPWpGaD
Propericiazine—Drowsiness—Gabapentin—migraine	0.0004	0.00283	CcSEcCtD
Propericiazine—Hypokalaemia—Topiramate—migraine	0.000397	0.00281	CcSEcCtD
Propericiazine—Diarrhoea—Amitriptyline—migraine	0.000396	0.0028	CcSEcCtD
Propericiazine—Triflupromazine—HTR2B—migraine	0.000396	0.0531	CrCbGaD
Propericiazine—Insomnia—Verapamil—migraine	0.000392	0.00278	CcSEcCtD
Propericiazine—Jaundice—Gabapentin—migraine	0.00039	0.00276	CcSEcCtD
Propericiazine—Arrhythmia—Valproic Acid—migraine	0.000387	0.00274	CcSEcCtD
Propericiazine—Dyspnoea—Verapamil—migraine	0.000387	0.00274	CcSEcCtD
Propericiazine—Somnolence—Verapamil—migraine	0.000386	0.00273	CcSEcCtD
Propericiazine—DRD1—G alpha (s) signalling events—CALCA—migraine	0.000385	0.00484	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000378	0.00474	CbGpPWpGaD
Propericiazine—DRD1—nerve—migraine	0.000378	0.223	CbGeAlD
Propericiazine—Asthma—Topiramate—migraine	0.000377	0.00267	CcSEcCtD
Propericiazine—Eosinophilia—Topiramate—migraine	0.000374	0.00264	CcSEcCtD
Propericiazine—Body temperature increased—Propranolol—migraine	0.000373	0.00264	CcSEcCtD
Propericiazine—Constipation—Verapamil—migraine	0.000371	0.00263	CcSEcCtD
Propericiazine—Vomiting—Amitriptyline—migraine	0.000368	0.00261	CcSEcCtD
Propericiazine—Sweating increased—Topiramate—migraine	0.000367	0.0026	CcSEcCtD
Propericiazine—Rash—Amitriptyline—migraine	0.000365	0.00258	CcSEcCtD
Propericiazine—DRD1—GPCR ligand binding—CALCRL—migraine	0.000365	0.00458	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—RAMP1—migraine	0.000365	0.00458	CbGpPWpGaD
Propericiazine—Dermatitis—Amitriptyline—migraine	0.000365	0.00258	CcSEcCtD
Propericiazine—DRD1—G alpha (s) signalling events—HTR7—migraine	0.00036	0.00452	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000358	0.00449	CbGpPWpGaD
Propericiazine—Cardiac disorder—Timolol—migraine	0.000358	0.00253	CcSEcCtD
Propericiazine—Vision blurred—Valproic Acid—migraine	0.000355	0.00251	CcSEcCtD
Propericiazine—Tremor—Valproic Acid—migraine	0.000353	0.0025	CcSEcCtD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000348	0.00437	CbGpPWpGaD
Propericiazine—Hypersensitivity—Propranolol—migraine	0.000347	0.00246	CcSEcCtD
Propericiazine—Erectile dysfunction—Topiramate—migraine	0.000347	0.00246	CcSEcCtD
Propericiazine—Agitation—Valproic Acid—migraine	0.000346	0.00245	CcSEcCtD
Propericiazine—Angioedema—Valproic Acid—migraine	0.000344	0.00244	CcSEcCtD
Propericiazine—Photosensitivity reaction—Topiramate—migraine	0.000344	0.00244	CcSEcCtD
Propericiazine—Arrhythmia—Timolol—migraine	0.000344	0.00244	CcSEcCtD
Propericiazine—Nausea—Amitriptyline—migraine	0.000344	0.00243	CcSEcCtD
Propericiazine—Weight increased—Topiramate—migraine	0.000343	0.00243	CcSEcCtD
Propericiazine—Hyperglycaemia—Topiramate—migraine	0.00034	0.00241	CcSEcCtD
Propericiazine—Pneumonia—Topiramate—migraine	0.000338	0.00239	CcSEcCtD
Propericiazine—Cardiac disorder—Gabapentin—migraine	0.000333	0.00236	CcSEcCtD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000333	0.00418	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000324	0.00406	CbGpPWpGaD
Propericiazine—Diarrhoea—Propranolol—migraine	0.000323	0.00228	CcSEcCtD
Propericiazine—Hypersensitivity—Verapamil—migraine	0.00032	0.00226	CcSEcCtD
Propericiazine—Vision blurred—Timolol—migraine	0.000316	0.00224	CcSEcCtD
Propericiazine—Agranulocytosis—Topiramate—migraine	0.000314	0.00222	CcSEcCtD
Propericiazine—Dry mouth—Valproic Acid—migraine	0.000314	0.00222	CcSEcCtD
Propericiazine—Confusional state—Valproic Acid—migraine	0.00031	0.0022	CcSEcCtD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.00031	0.00388	CbGpPWpGaD
Propericiazine—Oedema—Valproic Acid—migraine	0.000308	0.00218	CcSEcCtD
Propericiazine—Angioedema—Timolol—migraine	0.000307	0.00217	CcSEcCtD
Propericiazine—Infection—Valproic Acid—migraine	0.000306	0.00216	CcSEcCtD
Propericiazine—Tachycardia—Valproic Acid—migraine	0.0003	0.00212	CcSEcCtD
Propericiazine—Vomiting—Propranolol—migraine	0.0003	0.00212	CcSEcCtD
Propericiazine—ADRA1B—GPCR ligand binding—RAMP1—migraine	0.000299	0.00375	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CALCRL—migraine	0.000299	0.00375	CbGpPWpGaD
Propericiazine—Hyperhidrosis—Valproic Acid—migraine	0.000297	0.0021	CcSEcCtD
Propericiazine—Rash—Propranolol—migraine	0.000297	0.0021	CcSEcCtD
Propericiazine—Dermatitis—Propranolol—migraine	0.000297	0.0021	CcSEcCtD
Propericiazine—Diarrhoea—Verapamil—migraine	0.000297	0.0021	CcSEcCtD
Propericiazine—ADRA2A—G alpha (i) signalling events—HTR1D—migraine	0.000296	0.00372	CbGpPWpGaD
Propericiazine—Vision blurred—Gabapentin—migraine	0.000294	0.00208	CcSEcCtD
Propericiazine—Tremor—Gabapentin—migraine	0.000293	0.00207	CcSEcCtD
Propericiazine—Hypotension—Valproic Acid—migraine	0.000287	0.00203	CcSEcCtD
Propericiazine—Agitation—Gabapentin—migraine	0.000287	0.00203	CcSEcCtD
Propericiazine—Angioedema—Gabapentin—migraine	0.000285	0.00202	CcSEcCtD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000285	0.00358	CbGpPWpGaD
Propericiazine—DRD1—Circadian rythm related genes—NPS—migraine	0.000285	0.00358	CbGpPWpGaD
Propericiazine—ADRA1B—LPA receptor mediated events—FOS—migraine	0.000281	0.00352	CbGpPWpGaD
Propericiazine—Cardiac disorder—Topiramate—migraine	0.00028	0.00198	CcSEcCtD
Propericiazine—Nausea—Propranolol—migraine	0.00028	0.00198	CcSEcCtD
Propericiazine—DRD1—Circadian rythm related genes—SLC6A4—migraine	0.00028	0.00351	CbGpPWpGaD
Propericiazine—Dry mouth—Timolol—migraine	0.000279	0.00198	CcSEcCtD
Propericiazine—Cyamemazine—HTR2C—migraine	0.000279	0.0374	CrCbGaD
Propericiazine—Clomipramine—HTR2B—migraine	0.000279	0.0374	CrCbGaD
Propericiazine—Insomnia—Valproic Acid—migraine	0.000278	0.00197	CcSEcCtD
Propericiazine—Confusional state—Timolol—migraine	0.000276	0.00195	CcSEcCtD
Propericiazine—Vomiting—Verapamil—migraine	0.000276	0.00195	CcSEcCtD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000275	0.00345	CbGpPWpGaD
Propericiazine—Dyspnoea—Valproic Acid—migraine	0.000274	0.00194	CcSEcCtD
Propericiazine—Oedema—Timolol—migraine	0.000274	0.00194	CcSEcCtD
Propericiazine—Rash—Verapamil—migraine	0.000274	0.00194	CcSEcCtD
Propericiazine—Somnolence—Valproic Acid—migraine	0.000273	0.00194	CcSEcCtD
Propericiazine—Dermatitis—Verapamil—migraine	0.000273	0.00193	CcSEcCtD
Propericiazine—Infection—Timolol—migraine	0.000272	0.00193	CcSEcCtD
Propericiazine—DRD1—GPCR ligand binding—HTR1D—migraine	0.000265	0.00333	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000265	0.00333	CbGpPWpGaD
Propericiazine—Hyperhidrosis—Timolol—migraine	0.000265	0.00187	CcSEcCtD
Propericiazine—Constipation—Valproic Acid—migraine	0.000263	0.00186	CcSEcCtD
Propericiazine—Dry mouth—Gabapentin—migraine	0.00026	0.00184	CcSEcCtD
Propericiazine—Nausea—Verapamil—migraine	0.000258	0.00182	CcSEcCtD
Propericiazine—Confusional state—Gabapentin—migraine	0.000257	0.00182	CcSEcCtD
Propericiazine—Hypotension—Timolol—migraine	0.000256	0.00181	CcSEcCtD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	0.000255	0.00321	CbGpPWpGaD
Propericiazine—Oedema—Gabapentin—migraine	0.000255	0.0018	CcSEcCtD
Propericiazine—Infection—Gabapentin—migraine	0.000253	0.00179	CcSEcCtD
Propericiazine—Tachycardia—Gabapentin—migraine	0.000249	0.00176	CcSEcCtD
Propericiazine—Vision blurred—Topiramate—migraine	0.000248	0.00175	CcSEcCtD
Propericiazine—Insomnia—Timolol—migraine	0.000248	0.00175	CcSEcCtD
Propericiazine—ADRA1B—G alpha (q) signalling events—TAC1—migraine	0.000247	0.0031	CbGpPWpGaD
Propericiazine—ADRA1B—G alpha (q) signalling events—NPS—migraine	0.000247	0.0031	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—RAMP1—migraine	0.000247	0.0031	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—CALCRL—migraine	0.000247	0.0031	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—HTR2B—migraine	0.000247	0.00309	CbGpPWpGaD
Propericiazine—Hyperhidrosis—Gabapentin—migraine	0.000246	0.00174	CcSEcCtD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000246	0.00309	CbGpPWpGaD
Propericiazine—Tremor—Topiramate—migraine	0.000246	0.00174	CcSEcCtD
Propericiazine—DRD1—Circadian rythm related genes—HTR7—migraine	0.000245	0.00307	CbGpPWpGaD
Propericiazine—Dyspnoea—Timolol—migraine	0.000244	0.00173	CcSEcCtD
Propericiazine—Somnolence—Timolol—migraine	0.000243	0.00172	CcSEcCtD
Propericiazine—Body temperature increased—Valproic Acid—migraine	0.000243	0.00172	CcSEcCtD
Propericiazine—ADRA1B—G alpha (q) signalling events—HTR2C—migraine	0.000243	0.00304	CbGpPWpGaD
Propericiazine—Agitation—Topiramate—migraine	0.000242	0.00171	CcSEcCtD
Propericiazine—Quetiapine—HTR3A—migraine	0.000241	0.0324	CrCbGaD
Propericiazine—Quetiapine—HTR1D—migraine	0.000239	0.032	CrCbGaD
Propericiazine—Hypotension—Gabapentin—migraine	0.000238	0.00169	CcSEcCtD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000237	0.00298	CbGpPWpGaD
Propericiazine—ADRA1B—G alpha (q) signalling events—EDNRA—migraine	0.000236	0.00296	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	0.000235	0.00295	CbGpPWpGaD
Propericiazine—Insomnia—Gabapentin—migraine	0.000231	0.00163	CcSEcCtD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000229	0.00287	CbGpPWpGaD
Propericiazine—Dyspnoea—Gabapentin—migraine	0.000227	0.00161	CcSEcCtD
Propericiazine—Somnolence—Gabapentin—migraine	0.000227	0.0016	CcSEcCtD
Propericiazine—Hypersensitivity—Valproic Acid—migraine	0.000227	0.0016	CcSEcCtD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000223	0.0028	CbGpPWpGaD
Propericiazine—ADRA2A—peripheral nervous system—migraine	0.000222	0.131	CbGeAlD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	0.000221	0.00278	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	0.000221	0.00278	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	0.000219	0.00275	CbGpPWpGaD
Propericiazine—Dry mouth—Topiramate—migraine	0.000219	0.00155	CcSEcCtD
Propericiazine—Constipation—Gabapentin—migraine	0.000218	0.00154	CcSEcCtD
Propericiazine—ADRA1B—GPCR ligand binding—HTR1D—migraine	0.000217	0.00273	CbGpPWpGaD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—migraine	0.000217	0.00272	CbGpPWpGaD
Propericiazine—Body temperature increased—Timolol—migraine	0.000216	0.00153	CcSEcCtD
Propericiazine—Confusional state—Topiramate—migraine	0.000216	0.00153	CcSEcCtD
Propericiazine—Oedema—Topiramate—migraine	0.000215	0.00152	CcSEcCtD
Propericiazine—Infection—Topiramate—migraine	0.000213	0.00151	CcSEcCtD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	0.000211	0.00265	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000211	0.00265	CbGpPWpGaD
Propericiazine—Diarrhoea—Valproic Acid—migraine	0.00021	0.00149	CcSEcCtD
Propericiazine—Tachycardia—Topiramate—migraine	0.000209	0.00148	CcSEcCtD
Propericiazine—Hyperhidrosis—Topiramate—migraine	0.000207	0.00147	CcSEcCtD
Propericiazine—DRD1—GPCR downstream signaling—RAMP1—migraine	0.000206	0.00259	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CALCRL—migraine	0.000206	0.00259	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000203	0.00255	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR2B—migraine	0.000202	0.00253	CbGpPWpGaD
Propericiazine—Hypersensitivity—Timolol—migraine	0.000202	0.00143	CcSEcCtD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000202	0.00253	CbGpPWpGaD
Propericiazine—Body temperature increased—Gabapentin—migraine	0.000202	0.00143	CcSEcCtD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000201	0.00252	CbGpPWpGaD
Propericiazine—Hypotension—Topiramate—migraine	0.0002	0.00142	CcSEcCtD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.0002	0.00251	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.0002	0.00251	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000196	0.00246	CbGpPWpGaD
Propericiazine—Vomiting—Valproic Acid—migraine	0.000196	0.00138	CcSEcCtD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.000194	0.00244	CbGpPWpGaD
Propericiazine—Insomnia—Topiramate—migraine	0.000194	0.00137	CcSEcCtD
Propericiazine—Rash—Valproic Acid—migraine	0.000194	0.00137	CcSEcCtD
Propericiazine—Dermatitis—Valproic Acid—migraine	0.000194	0.00137	CcSEcCtD
Propericiazine—Dyspnoea—Topiramate—migraine	0.000191	0.00135	CcSEcCtD
Propericiazine—Chlorpromazine—HTR2B—migraine	0.000191	0.0256	CrCbGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000191	0.0024	CbGpPWpGaD
Propericiazine—Somnolence—Topiramate—migraine	0.000191	0.00135	CcSEcCtD
Propericiazine—Hypersensitivity—Gabapentin—migraine	0.000188	0.00133	CcSEcCtD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000188	0.00235	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—CALCRL—migraine	0.000187	0.00235	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—RAMP1—migraine	0.000187	0.00235	CbGpPWpGaD
Propericiazine—Diarrhoea—Timolol—migraine	0.000187	0.00133	CcSEcCtD
Propericiazine—Constipation—Topiramate—migraine	0.000183	0.0013	CcSEcCtD
Propericiazine—Nausea—Valproic Acid—migraine	0.000183	0.00129	CcSEcCtD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000182	0.00229	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—HTR1B—migraine	0.000179	0.00225	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR1D—migraine	0.000179	0.00225	CbGpPWpGaD
Propericiazine—Cyamemazine—HTR2A—migraine	0.000178	0.0238	CrCbGaD
Propericiazine—Diarrhoea—Gabapentin—migraine	0.000174	0.00123	CcSEcCtD
Propericiazine—Vomiting—Timolol—migraine	0.000174	0.00123	CcSEcCtD
Propericiazine—Acepromazine—HTR1A—migraine	0.000174	0.0233	CrCbGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000173	0.00217	CbGpPWpGaD
Propericiazine—ADRA2A—G alpha (i) signalling events—HTR1A—migraine	0.000173	0.00217	CbGpPWpGaD
Propericiazine—Rash—Timolol—migraine	0.000173	0.00122	CcSEcCtD
Propericiazine—Dermatitis—Timolol—migraine	0.000172	0.00122	CcSEcCtD
Propericiazine—Thiothixene—HTR2C—migraine	0.000172	0.0231	CrCbGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000172	0.00216	CbGpPWpGaD
Propericiazine—Mesoridazine—HTR2C—migraine	0.00017	0.0228	CrCbGaD
Propericiazine—Thioproperazine—HTR1A—migraine	0.00017	0.0228	CrCbGaD
Propericiazine—Body temperature increased—Topiramate—migraine	0.00017	0.0012	CcSEcCtD
Propericiazine—ADRA1B—GPCR downstream signaling—CALCRL—migraine	0.000169	0.00212	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—RAMP1—migraine	0.000169	0.00212	CbGpPWpGaD
Propericiazine—Pipotiazine—HTR1A—migraine	0.000167	0.0224	CrCbGaD
Propericiazine—Thiothixene—HTR1A—migraine	0.000167	0.0224	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR2B—migraine	0.000167	0.00209	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	0.000166	0.00209	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000166	0.00209	CbGpPWpGaD
Propericiazine—Mesoridazine—HTR1A—migraine	0.000165	0.0221	CrCbGaD
Propericiazine—Prochlorperazine—HTR2C—migraine	0.000165	0.0221	CrCbGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000164	0.00206	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000164	0.00206	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000164	0.00206	CbGpPWpGaD
Propericiazine—Nausea—Timolol—migraine	0.000163	0.00115	CcSEcCtD
Propericiazine—Thioridazine—HTR7—migraine	0.000163	0.0218	CrCbGaD
Propericiazine—DRD1—brainstem—migraine	0.000162	0.0956	CbGeAlD
Propericiazine—Vomiting—Gabapentin—migraine	0.000162	0.00115	CcSEcCtD
Propericiazine—Rash—Gabapentin—migraine	0.000161	0.00114	CcSEcCtD
Propericiazine—DRD1—GPCR ligand binding—HTR1B—migraine	0.000161	0.00202	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000161	0.00202	CbGpPWpGaD
Propericiazine—Dermatitis—Gabapentin—migraine	0.000161	0.00114	CcSEcCtD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	0.00016	0.00201	CbGpPWpGaD
Propericiazine—Hypersensitivity—Topiramate—migraine	0.000158	0.00112	CcSEcCtD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000156	0.00196	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2C—migraine	0.000155	0.00194	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—HTR1A—migraine	0.000155	0.00194	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—RAMP1—migraine	0.000153	0.00193	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CALCRL—migraine	0.000153	0.00193	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—TAC1—migraine	0.000152	0.00191	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—NPS—migraine	0.000152	0.00191	CbGpPWpGaD
Propericiazine—Nausea—Gabapentin—migraine	0.000151	0.00107	CcSEcCtD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	0.000151	0.00189	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR1D—migraine	0.00015	0.00188	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—HTR2C—migraine	0.000149	0.00188	CbGpPWpGaD
Propericiazine—Perphenazine—HTR7—migraine	0.000149	0.02	CrCbGaD
Propericiazine—Fluphenazine—HTR2C—migraine	0.000149	0.02	CrCbGaD
Propericiazine—ADRA1B—G alpha (q) signalling events—HTR2A—migraine	0.000149	0.00187	CbGpPWpGaD
Propericiazine—Diarrhoea—Topiramate—migraine	0.000147	0.00104	CcSEcCtD
Propericiazine—Quetiapine—HTR7—migraine	0.000146	0.0196	CrCbGaD
Propericiazine—DRD1—GPCR ligand binding—EDNRA—migraine	0.000145	0.00182	CbGpPWpGaD
Propericiazine—Fluphenazine—HTR1A—migraine	0.000145	0.0194	CrCbGaD
Propericiazine—Propiomazine—HTR2C—migraine	0.000143	0.0192	CrCbGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	0.000143	0.00179	CbGpPWpGaD
Propericiazine—Quetiapine—HTR1B—migraine	0.000142	0.019	CrCbGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000141	0.00177	CbGpPWpGaD
Propericiazine—DRD1—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.00014	0.00176	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—CALCA—migraine	0.00014	0.00176	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CALCRL—migraine	0.000139	0.00175	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—RAMP1—migraine	0.000139	0.00175	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR2B—migraine	0.000139	0.00175	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	0.000137	0.00172	CbGpPWpGaD
Propericiazine—Vomiting—Topiramate—migraine	0.000136	0.000965	CcSEcCtD
Propericiazine—Clomipramine—HTR2C—migraine	0.000136	0.0183	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—HTR1D—migraine	0.000136	0.00171	CbGpPWpGaD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—migraine	0.000136	0.0017	CbGpPWpGaD
Propericiazine—Rash—Topiramate—migraine	0.000135	0.000957	CcSEcCtD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	0.000135	0.0017	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	0.000135	0.0017	CbGpPWpGaD
Propericiazine—Dermatitis—Topiramate—migraine	0.000135	0.000956	CcSEcCtD
Propericiazine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	0.000133	0.00167	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—migraine	0.000133	0.00166	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR1B—migraine	0.000132	0.00165	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—HTR7—migraine	0.000131	0.00164	CbGpPWpGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	0.000129	0.00162	CbGpPWpGaD
Propericiazine—Thioridazine—HTR2C—migraine	0.000128	0.0172	CrCbGaD
Propericiazine—Nausea—Topiramate—migraine	0.000127	0.000902	CcSEcCtD
Propericiazine—Zuclopenthixol—HTR2A—migraine	0.000127	0.0171	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR1A—migraine	0.000127	0.00159	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CALCRL—migraine	0.000127	0.00159	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—RAMP1—migraine	0.000127	0.00159	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR2B—migraine	0.000127	0.00159	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—NPS—migraine	0.000125	0.00157	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—TAC1—migraine	0.000125	0.00157	CbGpPWpGaD
Propericiazine—Thioridazine—HTR1A—migraine	0.000125	0.0167	CrCbGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR1D—migraine	0.000123	0.00154	CbGpPWpGaD
Propericiazine—Methotrimeprazine—HTR2C—migraine	0.000122	0.0164	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR2C—migraine	0.000122	0.00154	CbGpPWpGaD
Propericiazine—DRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	0.00012	0.00151	CbGpPWpGaD
Propericiazine—Trifluoperazine—HTR2C—migraine	0.000119	0.016	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—EDNRA—migraine	0.000119	0.00149	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR7—migraine	0.000118	0.0159	CrCbGaD
Propericiazine—Perphenazine—HTR2C—migraine	0.000118	0.0158	CrCbGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	0.000116	0.00146	CbGpPWpGaD
Propericiazine—Trifluoperazine—HTR1A—migraine	0.000116	0.0155	CrCbGaD
Propericiazine—Quetiapine—HTR2C—migraine	0.000115	0.0155	CrCbGaD
Propericiazine—ADRA1B—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	0.000115	0.00144	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR ligand binding—CALCA—migraine	0.000115	0.00144	CbGpPWpGaD
Propericiazine—Perphenazine—HTR1A—migraine	0.000114	0.0153	CrCbGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR2B—migraine	0.000114	0.00143	CbGpPWpGaD
Propericiazine—Acepromazine—HTR2A—migraine	0.000114	0.0153	CrCbGaD
Propericiazine—Clomipramine—SLC6A4—migraine	0.000113	0.0151	CrCbGaD
Propericiazine—Quetiapine—HTR1A—migraine	0.000112	0.015	CrCbGaD
Propericiazine—Thioproperazine—HTR2A—migraine	0.000112	0.015	CrCbGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR1D—migraine	0.000111	0.0014	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CALCRL—migraine	0.000111	0.00139	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—RAMP1—migraine	0.000111	0.00139	CbGpPWpGaD
Propericiazine—Thiothixene—HTR2A—migraine	0.00011	0.0147	CrCbGaD
Propericiazine—Pipotiazine—HTR2A—migraine	0.00011	0.0147	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR1B—migraine	0.000109	0.00136	CbGpPWpGaD
Propericiazine—Mesoridazine—HTR2A—migraine	0.000108	0.0145	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR7—migraine	0.000107	0.00134	CbGpPWpGaD
Propericiazine—Promazine—HTR2C—migraine	0.000106	0.0142	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR1A—migraine	0.000105	0.00131	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR2B—migraine	0.000104	0.0013	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—TAC1—migraine	0.000103	0.00129	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—NPS—migraine	0.000103	0.00129	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR1D—migraine	0.000101	0.00127	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR2C—migraine	0.000101	0.00127	CbGpPWpGaD
Propericiazine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	9.86e-05	0.00124	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—EDNRA—migraine	9.82e-05	0.00123	CbGpPWpGaD
Propericiazine—ADRA1B—head—migraine	9.62e-05	0.0567	CbGeAlD
Propericiazine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	9.49e-05	0.00119	CbGpPWpGaD
Propericiazine—Fluphenazine—HTR2A—migraine	9.48e-05	0.0127	CrCbGaD
Propericiazine—ADRA2A—GPCR ligand binding—CALCA—migraine	9.46e-05	0.00119	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR2B—migraine	9.42e-05	0.00118	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR2C—migraine	9.34e-05	0.0125	CrCbGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR1D—migraine	9.2e-05	0.00115	CbGpPWpGaD
Propericiazine—DRD1—GPCR ligand binding—HTR2A—migraine	9.17e-05	0.00115	CbGpPWpGaD
Propericiazine—Propiomazine—HTR2A—migraine	9.12e-05	0.0122	CrCbGaD
Propericiazine—ADRA1B—nervous system—migraine	9.12e-05	0.0537	CbGeAlD
Propericiazine—DRD1—GPCR downstream signaling—HTR1B—migraine	9.08e-05	0.00114	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR1A—migraine	9.07e-05	0.0122	CrCbGaD
Propericiazine—ADRA1B—Signaling Pathways—RAMP1—migraine	9.06e-05	0.00114	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CALCRL—migraine	9.06e-05	0.00114	CbGpPWpGaD
Propericiazine—DRD1—head—migraine	8.97e-05	0.0528	CbGeAlD
Propericiazine—ADRA2A—GPCR ligand binding—HTR7—migraine	8.84e-05	0.00111	CbGpPWpGaD
Propericiazine—ADRA1B—central nervous system—migraine	8.78e-05	0.0517	CbGeAlD
Propericiazine—DRD1—GPCR downstream signaling—HTR1A—migraine	8.74e-05	0.0011	CbGpPWpGaD
Propericiazine—Clomipramine—HTR2A—migraine	8.67e-05	0.0116	CrCbGaD
Propericiazine—DRD1—GPCR downstream signaling—TAC1—migraine	8.61e-05	0.00108	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—NPS—migraine	8.61e-05	0.00108	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR2B—migraine	8.55e-05	0.00107	CbGpPWpGaD
Propericiazine—DRD1—nervous system—migraine	8.5e-05	0.0501	CbGeAlD
Propericiazine—DRD1—GPCR downstream signaling—HTR2C—migraine	8.44e-05	0.00106	CbGpPWpGaD
Propericiazine—ADRA2A—trigeminal ganglion—migraine	8.4e-05	0.0495	CbGeAlD
Propericiazine—DRD1—Signaling by GPCR—HTR1B—migraine	8.25e-05	0.00104	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—EDNRA—migraine	8.21e-05	0.00103	CbGpPWpGaD
Propericiazine—DRD1—central nervous system—migraine	8.18e-05	0.0482	CbGeAlD
Propericiazine—Thioridazine—HTR2A—migraine	8.17e-05	0.011	CrCbGaD
Propericiazine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	8.13e-05	0.00102	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR1D—migraine	8.04e-05	0.00101	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR1A—migraine	7.94e-05	0.000996	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—CALCA—migraine	7.91e-05	0.000992	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—NPS—migraine	7.82e-05	0.000981	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—TAC1—migraine	7.82e-05	0.000981	CbGpPWpGaD
Propericiazine—Methotrimeprazine—HTR2A—migraine	7.8e-05	0.0105	CrCbGaD
Propericiazine—Promethazine—HTR2A—migraine	7.68e-05	0.0103	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—HTR2C—migraine	7.67e-05	0.000962	CbGpPWpGaD
Propericiazine—Trifluoperazine—HTR2A—migraine	7.58e-05	0.0102	CrCbGaD
Propericiazine—ADRA1B—GPCR ligand binding—HTR2A—migraine	7.51e-05	0.000942	CbGpPWpGaD
Propericiazine—Perphenazine—HTR2A—migraine	7.5e-05	0.0101	CrCbGaD
Propericiazine—ADRA2A—Signaling Pathways—RAMP1—migraine	7.48e-05	0.000939	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CALCRL—migraine	7.48e-05	0.000939	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR2B—migraine	7.48e-05	0.000938	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—EDNRA—migraine	7.46e-05	0.000936	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR1B—migraine	7.44e-05	0.000933	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR7—migraine	7.4e-05	0.000928	CbGpPWpGaD
Propericiazine—Quetiapine—HTR2A—migraine	7.35e-05	0.00986	CrCbGaD
Propericiazine—DRD1—Signaling by GPCR—CALCA—migraine	7.18e-05	0.000901	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR1A—migraine	7.16e-05	0.000898	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—TAC1—migraine	7.05e-05	0.000885	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—NPS—migraine	7.05e-05	0.000885	CbGpPWpGaD
Propericiazine—ADRA1B—brain—migraine	6.97e-05	0.0411	CbGeAlD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR2C—migraine	6.91e-05	0.000868	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—CACNA1A—migraine	6.78e-05	0.000851	CbGpPWpGaD
Propericiazine—Promazine—HTR2A—migraine	6.76e-05	0.00906	CrCbGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR1B—migraine	6.75e-05	0.000848	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—EDNRA—migraine	6.73e-05	0.000844	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR7—migraine	6.72e-05	0.000843	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR1D—migraine	6.59e-05	0.000826	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—LRP1—migraine	6.58e-05	0.000826	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR1A—migraine	6.5e-05	0.000816	CbGpPWpGaD
Propericiazine—DRD1—brain—migraine	6.5e-05	0.0383	CbGeAlD
Propericiazine—ADRA1B—GPCR downstream signaling—CALCA—migraine	6.47e-05	0.000813	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—TAC1—migraine	6.4e-05	0.000804	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—NPS—migraine	6.4e-05	0.000804	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR2C—migraine	6.28e-05	0.000788	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR ligand binding—HTR2A—migraine	6.19e-05	0.000777	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR1B—migraine	6.14e-05	0.00077	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR2B—migraine	6.12e-05	0.000768	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—EDNRA—migraine	6.11e-05	0.000767	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR7—migraine	6.06e-05	0.00076	CbGpPWpGaD
Propericiazine—Chlorpromazine—HTR2A—migraine	5.95e-05	0.00798	CrCbGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR1A—migraine	5.91e-05	0.000742	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—CALCA—migraine	5.88e-05	0.000738	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—TAC1—migraine	5.82e-05	0.00073	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—NPS—migraine	5.82e-05	0.00073	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR2C—migraine	5.71e-05	0.000716	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR1B—migraine	5.57e-05	0.0007	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—EDNRA—migraine	5.55e-05	0.000697	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling by GPCR—HTR7—migraine	5.5e-05	0.00069	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR1D—migraine	5.43e-05	0.000682	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—LRP1—migraine	5.39e-05	0.000676	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR1A—migraine	5.37e-05	0.000673	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—CALCA—migraine	5.34e-05	0.000671	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—TAC1—migraine	5.28e-05	0.000663	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—NPS—migraine	5.28e-05	0.000663	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR2C—migraine	5.18e-05	0.00065	CbGpPWpGaD
Propericiazine—DRD1—GPCR downstream signaling—HTR2A—migraine	5.18e-05	0.00065	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2B—migraine	5.05e-05	0.000634	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH4—migraine	5.05e-05	0.000634	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—EDNRA—migraine	5.04e-05	0.000633	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR7—migraine	5e-05	0.000627	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR1B—migraine	4.87e-05	0.000611	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—CALCA—migraine	4.85e-05	0.000609	CbGpPWpGaD
Propericiazine—DRD1—Signaling by GPCR—HTR2A—migraine	4.7e-05	0.00059	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR1A—migraine	4.69e-05	0.000589	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TAC1—migraine	4.62e-05	0.00058	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—PGR—migraine	4.62e-05	0.00058	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NPS—migraine	4.62e-05	0.00058	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR7—migraine	4.54e-05	0.00057	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR2C—migraine	4.53e-05	0.000568	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—LRP1—migraine	4.45e-05	0.000558	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—EDNRA—migraine	4.41e-05	0.000553	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—NOTCH3—migraine	4.29e-05	0.000539	CbGpPWpGaD
Propericiazine—ADRA1B—GPCR downstream signaling—HTR2A—migraine	4.24e-05	0.000532	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—CALCA—migraine	4.24e-05	0.000532	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH4—migraine	4.14e-05	0.000519	CbGpPWpGaD
Propericiazine—ADRA2A—head—migraine	4.11e-05	0.0242	CbGeAlD
Propericiazine—ADRA1B—Signaling Pathways—HTR1B—migraine	3.99e-05	0.000501	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR7—migraine	3.97e-05	0.000498	CbGpPWpGaD
Propericiazine—ADRA2A—nervous system—migraine	3.9e-05	0.023	CbGeAlD
Propericiazine—ADRA1B—Signaling by GPCR—HTR2A—migraine	3.85e-05	0.000483	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR1A—migraine	3.84e-05	0.000482	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TAC1—migraine	3.78e-05	0.000475	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—PGR—migraine	3.78e-05	0.000475	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NPS—migraine	3.78e-05	0.000475	CbGpPWpGaD
Propericiazine—ADRA2A—central nervous system—migraine	3.75e-05	0.0221	CbGeAlD
Propericiazine—ADRA1B—Signaling Pathways—HTR2C—migraine	3.71e-05	0.000465	CbGpPWpGaD
Propericiazine—ADRA2A—cerebellum—migraine	3.67e-05	0.0216	CbGeAlD
Propericiazine—ADRA1B—Signaling Pathways—EDNRA—migraine	3.61e-05	0.000453	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—NOTCH3—migraine	3.52e-05	0.000441	CbGpPWpGaD
Propericiazine—ADRA2A—GPCR downstream signaling—HTR2A—migraine	3.5e-05	0.000439	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—CALCA—migraine	3.47e-05	0.000436	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—TGFBR2—migraine	3.42e-05	0.000429	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH4—migraine	3.41e-05	0.000428	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR1B—migraine	3.29e-05	0.000413	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR7—migraine	3.25e-05	0.000408	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling by GPCR—HTR2A—migraine	3.18e-05	0.000399	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR1A—migraine	3.17e-05	0.000398	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TAC1—migraine	3.12e-05	0.000392	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—PGR—migraine	3.12e-05	0.000392	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—NPS—migraine	3.12e-05	0.000392	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2C—migraine	3.06e-05	0.000384	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—EDNRA—migraine	2.98e-05	0.000374	CbGpPWpGaD
Propericiazine—ADRA2A—brain—migraine	2.98e-05	0.0175	CbGeAlD
Propericiazine—ADRA2A—Signaling Pathways—NOTCH3—migraine	2.9e-05	0.000364	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—CALCA—migraine	2.87e-05	0.00036	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—TGFBR2—migraine	2.8e-05	0.000351	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—HTR2A—migraine	2.78e-05	0.000349	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR7—migraine	2.68e-05	0.000336	CbGpPWpGaD
Propericiazine—DRD1—Signaling Pathways—ESR1—migraine	2.47e-05	0.000309	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—TGFBR2—migraine	2.31e-05	0.00029	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—HTR2A—migraine	2.28e-05	0.000286	CbGpPWpGaD
Propericiazine—ADRA2A—Metabolism—MTHFR—migraine	2.24e-05	0.000281	CbGpPWpGaD
Propericiazine—ADRA1B—Signaling Pathways—ESR1—migraine	2.02e-05	0.000253	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—HTR2A—migraine	1.88e-05	0.000236	CbGpPWpGaD
Propericiazine—ADRA2A—Signaling Pathways—ESR1—migraine	1.67e-05	0.000209	CbGpPWpGaD
